Abstract
This year there are many trials, guidelines and congress in CAD. The highlights are the intravascular inmaging studies especially OCT in complex lesions; the value of CCTA in diagnostic, estimate lesions and decision-making. The ORBITA-2 study: PCI in stable anginal patients who are not receiving antianginal medications.